Shattuck Labs inks $118m Series B

Durham, North Carolina and Austin-based Shattuck Labs Inc, a clinical-stage biotechnology company, has raised $118 million in Series B financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this